Navigation Links
HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College

SAN DIEGO, Calif., Sept. 8, 2011 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's pharmaceutical innovations, today announced a strategic partnership with the Zhejiang Chinese Medical University Life Science College. The collaboration agreement will accelerate the global drug development of China's novel Traditional Chinese Medicines (TCM).

The partnership is expected to bring productive synergy between the two parties. Zhejiang Chinese Medical University Life Science College, a prominent traditional Chinese medicine university in southern China, is recognized for its strength in leading-edge research in TCM.  HUYA has a strong commitment toward developing novel therapeutics from TCM in areas of unmet medical needs.  HBI-3000, HUYA's novel anti-arrhythmic compound currently in development in both China and the U.S., was originally derived from a TCM.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutions throughout China and has pioneered in-licensing innovative compounds from the country, utilizing its expertise to advance these compounds for global markets.

"The alliance with Zhejiang Chinese Medical University Life Science College will further strengthen HUYA's collaborative efforts with the faculty and researchers of the university," said Clement Gingras, HUYA's CTO and COO, China. "Together, HUYA and Zhejiang Chinese Medical University Life Science College will help advance the progression of TCM to the global markets, benefiting patients worldwide."

Dr. Zhishan Ding, Associate Dean of Zhejiang Chinese Medical University Life Science College, commented, "Our College is dedicated to promoting TCM innovations. We are delighted to collaborate with HUYA and together we will share the commitment towards the global development of novel therapeutics from TCM in areas of unmet medical need."


HUYA is the leader in global pharmaceutical co-development with Chinese partners. With seven offices strategically located in China, the most comprehensive Chinese compound portfolio, and a rapidly growing number of exclusive agreements with premier Chinese research and development organizations, HUYA is uniquely positioned to identify and license novel Chinese compounds. HUYA offers Western pharmaceutical companies efficient access to innovative therapeutic opportunities and helps to reduce deal-making complexity in China. The company has become a champion of guiding China's biomedical innovations to the worldwide marketplace. HUYA has joint headquarter offices in San Diego, CA, USA and Shanghai, China. Additional information about the company is available at


Zhejiang Chinese Medical University Life Science College, established in April 2000, is a successor of the Institute of Molecular Medicine. The college has six research departments: Biochemistry, Genetics and Molecular Biology, Cell Biology, Microbiology and Immunology, General Biology, and Clinical Laboratory Science. With well-defined missions, elite faculty, and outstanding educational subjects, Zhejiang Chinese Medical University Life Science College is now a leading institute for TCM in China. It has received various awards, developed two new drugs (one successfully marketed), undertaken a significant number of projects, and published numerous papers. For more information, please visit


Yung-Chih Wang, Ph.D., MBA
Vice President, Corporate Development, China
HUYA Bioscience International

Qing (Vicky) Xia, MS, MBA
Senior Business Development Manager
HUYA Bioscience International

SOURCE HUYA Bioscience International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad
2. Avantra Biosciences Changes Company Name to Courtagen Life Sciences, Inc.
3. BD Biosciences Announces Winners of Research Grant Program
4. 3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer
5. Numira Biosciences Names New Board Member
6. Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
7. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
8. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
9. Neurocrine Biosciences Reports Second Quarter 2011 Results
10. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
11. Roka Bioscience Participates in the International Association for Food Protection Conference
Post Your Comments:
(Date:10/8/2015)... Oct. 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, today announced ... meetings taking place in the month of October: ... Forum RepliCel will be presenting at the annual ... the Mesa to be held October 7-9 in ...
(Date:10/8/2015)... TORONTO, CANADA (PRWEB) , ... October 08, 2015 ... ... it has entered into an exclusive license agreement to develop and commercialize intellectual ... expands upon the original agreement from February 2009, and affords exclusive worldwide rights ...
(Date:10/7/2015)... ... 07, 2015 , ... Neil Riordan, PhD to Discuss Medicinal Effects of Mesenchymal ... Mar-a-Lago from 3:50 pm to 4:30 pm. , Dr. Riordan is one of the ... He is the Co-Founder and Chief Science Officer of the Riordan-McKenna Institute ...
(Date:10/7/2015)...   PDI , a leader in infection prevention ... key challenges across various healthcare settings, as well as ... This tool is part of a larger effort to ... efficiencies and lower healthcare-associated infections. ... of how to use the right product, in the ...
Breaking Biology Technology:
... Annual Samter Journalism Awards ... Entry Deadline: October 31, 2007, MILWAUKEE, ... (AAAAI), the largest professional medical specialty,organization in the United States ... a special interest in the research and treatment of allergic ...
... CALGARY, Sept. 28 /PRNewswire-FirstCall/ - Oncolytics Biotech ... oral,presentation covering interim results from a U.K. ... for patients with advanced or,metastatic cancers is ... Cancer,Research Institute (NCRI) conference on October 2, ...
... Sept. 28 Cynosure, Inc.,(Nasdaq: CYNO ), ... array of,light-based aesthetic treatment systems, today announced that ... Company/MEDACorp Aesthetics Roundtable,Conference. Chief Financial Officer Timothy ... recent financial results in a presentation,beginning at 2:10 ...
Cached Biology Technology:
(Date:10/8/2015)... , 8. Oktober 2015 Die ... tätiges Unternehmen des Bereiches Tracking, hat heute ... der Gefängnisbehörde Virginias (Department of Corrections – ... Überwachungsdienste für alle Strafen geliefert werden, die ... , Präsident für den Amerikanischen Kontinent der ...
(Date:10/7/2015)... October 8, 2015 --> ... Fingerprint Cards (FPC) during third quarter 2015 amounted to around ... around 860 MSEK that was communicated 20 August 2015. ... strengthened delivery capacity and a continued growing demand for the ... estimated to be higher than during the third quarter. The ...
(Date:10/6/2015)... Oct. 6, 2015 Track Group, Inc. (OTCQX: ... it has signed a contract with the Virginia Department ... full range of sentences under the Department,s oversight. ... Americas. "This contract with the Virginia DOC will expand ... and advances our position as a trusted leader in ...
Breaking Biology News(10 mins):
... Columbia have been able to pinpoint more of the ... valuable compounds to the roasting process. Lead author ... the prevailing antioxidants present in dark roasted coffee brew ... high temperatures. Their findings will appear in ...
... Zaragoza (UNIZAR) has studied precipitation trends in Spain,s 10 ... results show that precipitation has declined overall between the ... the rainy season. The rains are heavier in October ... 1946, the average precipitation falling on Spanish hydrological basins ...
... a serious environmental, economic and social problem worldwide as ... ecosystem functions, such as nutrient cycling. Despite substantial research, ... new habitats over native plants that technically should have ... is that these plants are more abundant in introduced ...
Cached Biology News:
Human IL-19 MAb (Clone 152112)...
geminin, DNA replication inhibitor...
Cytidine 5'-Triphosphate, Sodium (CTP), 1 g. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
Human IL-17D Affinity Purified Polyclonal Ab...
Biology Products: